第VIII因子欠乏症治療の世界市場 2020年

• 英文タイトル：Global Factor VIII Deficiency Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114400 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、第VIII因子欠乏症治療の世界市場を調査対象にし、第VIII因子欠乏症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別分析（病院、診療所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Pfizer、Kedrion、CSL、Takeda、F. Hoffmann-La Roche、Bayer HealthCare、Biogen Idec、Novo Nordisk、Grifols、Octapharma、Uniqure NV、BioMarin Pharmaceutical、Amarna Therapeutics、Swedish Orphan Biovitrum、Sangamo Therapeutics、Dimension Therapeutics、Spark Therapeutics ・企業別売上、市場シェア ・第VIII因子欠乏症治療の地域別市場分析 ・第VIII因子欠乏症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・第VIII因子欠乏症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・第VIII因子欠乏症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・第VIII因子欠乏症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・第VIII因子欠乏症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・第VIII因子欠乏症治療の種類別市場規模2015-2020：血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療 ・第VIII因子欠乏症治療の用途別市場規模2015-2020：病院、診療所、その他 ・第VIII因子欠乏症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Factor VIII Deficiency Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Factor VIII Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Factor VIII Deficiency Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Factor VIII Deficiency Treatment market has been segmented into:
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment

By Application, Factor VIII Deficiency Treatment has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Factor VIII Deficiency Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Factor VIII Deficiency Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Factor VIII Deficiency Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Factor VIII Deficiency Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Factor VIII Deficiency Treatment Market Share Analysis
Factor VIII Deficiency Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Factor VIII Deficiency Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Factor VIII Deficiency Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Factor VIII Deficiency Treatment are:
Pfizer
Kedrion
CSL
Takeda
F. Hoffmann-La Roche
Bayer HealthCare
Biogen Idec
Novo Nordisk
Grifols
Octapharma
Uniqure NV
BioMarin Pharmaceutical
Amarna Therapeutics
Swedish Orphan Biovitrum
Sangamo Therapeutics
Dimension Therapeutics
Spark Therapeutics

レポート目次

---

Table of Contents

1 Factor VIII Deficiency Treatment Market Overview
1.1 Product Overview and Scope of Factor VIII Deficiency Treatment
1.2 Classification of Factor VIII Deficiency Treatment by Type
1.2.1 Global Factor VIII Deficiency Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Type in 2019
1.2.3 Hemophilia A Drugs
1.2.4 Hemophilia A Inhibitors Treatment
1.2.5 Von Willebrand Disease Treatment
1.3 Global Factor VIII Deficiency Treatment Market by Application
1.3.1 Overview: Global Factor VIII Deficiency Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Factor VIII Deficiency Treatment Market by Regions
1.4.1 Global Factor VIII Deficiency Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Factor VIII Deficiency Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Factor VIII Deficiency Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Factor VIII Deficiency Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Factor VIII Deficiency Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Factor VIII Deficiency Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Factor VIII Deficiency Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kedrion
2.2.1 Kedrion Details
2.2.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kedrion SWOT Analysis
2.2.4 Kedrion Product and Services
2.2.5 Kedrion Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CSL SWOT Analysis
2.3.4 CSL Product and Services
2.3.5 CSL Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche SWOT Analysis
2.5.4 F. Hoffmann-La Roche Product and Services
2.5.5 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer HealthCare
2.6.1 Bayer HealthCare Details
2.6.2 Bayer HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer HealthCare SWOT Analysis
2.6.4 Bayer HealthCare Product and Services
2.6.5 Bayer HealthCare Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen Idec
2.7.1 Biogen Idec Details
2.7.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biogen Idec SWOT Analysis
2.7.4 Biogen Idec Product and Services
2.7.5 Biogen Idec Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novo Nordisk
2.8.1 Novo Nordisk Details
2.8.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novo Nordisk SWOT Analysis
2.8.4 Novo Nordisk Product and Services
2.8.5 Novo Nordisk Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Grifols
2.9.1 Grifols Details
2.9.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Grifols SWOT Analysis
2.9.4 Grifols Product and Services
2.9.5 Grifols Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Octapharma
2.10.1 Octapharma Details
2.10.2 Octapharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Octapharma SWOT Analysis
2.10.4 Octapharma Product and Services
2.10.5 Octapharma Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Uniqure NV
2.11.1 Uniqure NV Details
2.11.2 Uniqure NV Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Uniqure NV SWOT Analysis
2.11.4 Uniqure NV Product and Services
2.11.5 Uniqure NV Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 BioMarin Pharmaceutical
2.12.1 BioMarin Pharmaceutical Details
2.12.2 BioMarin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 BioMarin Pharmaceutical SWOT Analysis
2.12.4 BioMarin Pharmaceutical Product and Services
2.12.5 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Amarna Therapeutics
2.13.1 Amarna Therapeutics Details
2.13.2 Amarna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Amarna Therapeutics SWOT Analysis
2.13.4 Amarna Therapeutics Product and Services
2.13.5 Amarna Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Swedish Orphan Biovitrum
2.14.1 Swedish Orphan Biovitrum Details
2.14.2 Swedish Orphan Biovitrum Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Swedish Orphan Biovitrum SWOT Analysis
2.14.4 Swedish Orphan Biovitrum Product and Services
2.14.5 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sangamo Therapeutics
2.15.1 Sangamo Therapeutics Details
2.15.2 Sangamo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Sangamo Therapeutics SWOT Analysis
2.15.4 Sangamo Therapeutics Product and Services
2.15.5 Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Dimension Therapeutics
2.16.1 Dimension Therapeutics Details
2.16.2 Dimension Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Dimension Therapeutics SWOT Analysis
2.16.4 Dimension Therapeutics Product and Services
2.16.5 Dimension Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Spark Therapeutics
2.17.1 Spark Therapeutics Details
2.17.2 Spark Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Spark Therapeutics SWOT Analysis
2.17.4 Spark Therapeutics Product and Services
2.17.5 Spark Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Factor VIII Deficiency Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Factor VIII Deficiency Treatment Players Market Share
3.2.2 Top 10 Factor VIII Deficiency Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Factor VIII Deficiency Treatment Revenue and Market Share by Regions
4.2 North America Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
5 North America Factor VIII Deficiency Treatment Revenue by Countries
5.1 North America Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
5.2 USA Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
6 Europe Factor VIII Deficiency Treatment Revenue by Countries
6.1 Europe Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
6.2 Germany Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.4 France Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Countries
7.1 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
7.2 China Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.5 India Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
8 South America Factor VIII Deficiency Treatment Revenue by Countries
8.1 South America Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
8.2 Brazil Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Factor VIII Deficiency Treatment by Countries
9.1 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Factor VIII Deficiency Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Factor VIII Deficiency Treatment Market Forecast by Type (2019-2024)
10.3 Hemophilia A Drugs Revenue Growth Rate (2015-2025)
10.4 Hemophilia A Inhibitors Treatment Revenue Growth Rate (2015-2025)
10.5 Von Willebrand Disease Treatment Revenue Growth Rate (2015-2025)
11 Global Factor VIII Deficiency Treatment Market Segment by Application
11.1 Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2015-2020)
11.2 Factor VIII Deficiency Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Factor VIII Deficiency Treatment Market Size Forecast (2021-2025)
12.1 Global Factor VIII Deficiency Treatment Market Size Forecast (2021-2025)
12.2 Global Factor VIII Deficiency Treatment Market Forecast by Regions (2021-2025)
12.3 North America Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
12.6 South America Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Factor VIII Deficiency Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Factor VIII Deficiency Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Factor VIII Deficiency Treatment Major Business
Table 7. Pfizer Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Factor VIII Deficiency Treatment Product and Solutions
Table 10. Pfizer Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kedrion Corporate Information, Location and Competitors
Table 12. Kedrion Factor VIII Deficiency Treatment Major Business
Table 13. Kedrion Factor VIII Deficiency Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Kedrion SWOT Analysis
Table 15. Kedrion Factor VIII Deficiency Treatment Product and Solutions
Table 16. Kedrion Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. CSL Corporate Information, Location and Competitors
Table 18. CSL Factor VIII Deficiency Treatment Major Business
Table 19. CSL Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 20. CSL SWOT Analysis
Table 21. CSL Factor VIII Deficiency Treatment Product and Solutions
Table 22. CSL Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Takeda Corporate Information, Location and Competitors
Table 24. Takeda Factor VIII Deficiency Treatment Major Business
Table 25. Takeda Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Takeda SWOT Analysis
Table 27. Takeda Factor VIII Deficiency Treatment Product and Solutions
Table 28. Takeda Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 30. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Major Business
Table 31. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 32. F. Hoffmann-La Roche SWOT Analysis
Table 33. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product and Solutions
Table 34. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bayer HealthCare Corporate Information, Location and Competitors
Table 36. Bayer HealthCare Factor VIII Deficiency Treatment Major Business
Table 37. Bayer HealthCare Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Bayer HealthCare SWOT Analysis
Table 39. Bayer HealthCare Factor VIII Deficiency Treatment Product and Solutions
Table 40. Bayer HealthCare Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Biogen Idec Corporate Information, Location and Competitors
Table 42. Biogen Idec Factor VIII Deficiency Treatment Major Business
Table 43. Biogen Idec Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Biogen Idec SWOT Analysis
Table 45. Biogen Idec Factor VIII Deficiency Treatment Product and Solutions
Table 46. Biogen Idec Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novo Nordisk Corporate Information, Location and Competitors
Table 48. Novo Nordisk Factor VIII Deficiency Treatment Major Business
Table 49. Novo Nordisk Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Novo Nordisk SWOT Analysis
Table 51. Novo Nordisk Factor VIII Deficiency Treatment Product and Solutions
Table 52. Novo Nordisk Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Grifols Corporate Information, Location and Competitors
Table 54. Grifols Factor VIII Deficiency Treatment Major Business
Table 55. Grifols Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Grifols SWOT Analysis
Table 57. Grifols Factor VIII Deficiency Treatment Product and Solutions
Table 58. Grifols Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Octapharma Corporate Information, Location and Competitors
Table 60. Octapharma Factor VIII Deficiency Treatment Major Business
Table 61. Octapharma Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Octapharma SWOT Analysis
Table 63. Octapharma Factor VIII Deficiency Treatment Product and Solutions
Table 64. Octapharma Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Uniqure NV Corporate Information, Location and Competitors
Table 66. Uniqure NV Factor VIII Deficiency Treatment Major Business
Table 67. Uniqure NV Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Uniqure NV SWOT Analysis
Table 69. Uniqure NV Factor VIII Deficiency Treatment Product and Solutions
Table 70. Uniqure NV Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. BioMarin Pharmaceutical Corporate Information, Location and Competitors
Table 72. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Major Business
Table 73. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 74. BioMarin Pharmaceutical SWOT Analysis
Table 75. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Solutions
Table 76. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Amarna Therapeutics Corporate Information, Location and Competitors
Table 78. Amarna Therapeutics Factor VIII Deficiency Treatment Major Business
Table 79. Amarna Therapeutics Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Amarna Therapeutics SWOT Analysis
Table 81. Amarna Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 82. Amarna Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Swedish Orphan Biovitrum Corporate Information, Location and Competitors
Table 84. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Major Business
Table 85. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Swedish Orphan Biovitrum SWOT Analysis
Table 87. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product and Solutions
Table 88. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Sangamo Therapeutics Corporate Information, Location and Competitors
Table 90. Sangamo Therapeutics Factor VIII Deficiency Treatment Major Business
Table 91. Sangamo Therapeutics Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Sangamo Therapeutics SWOT Analysis
Table 93. Sangamo Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 94. Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Dimension Therapeutics Corporate Information, Location and Competitors
Table 96. Dimension Therapeutics Factor VIII Deficiency Treatment Major Business
Table 97. Dimension Therapeutics Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 98. Dimension Therapeutics SWOT Analysis
Table 99. Dimension Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 100. Dimension Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Spark Therapeutics Corporate Information, Location and Competitors
Table 102. Spark Therapeutics Factor VIII Deficiency Treatment Major Business
Table 103. Spark Therapeutics Factor VIII Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Spark Therapeutics SWOT Analysis
Table 105. Spark Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 106. Spark Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Factor VIII Deficiency Treatment Revenue (Million USD) by Players (2015-2020)
Table 108. Global Factor VIII Deficiency Treatment Revenue Share by Players (2015-2020)
Table 109. Global Factor VIII Deficiency Treatment Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Factor VIII Deficiency Treatment Revenue Market Share by Regions (2015-2020)
Table 111. North America Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
Table 112. North America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Table 113. Europe Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Factor VIII Deficiency Treatment Revenue by Countries (2015-2020)
Table 116. South America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Table 119. Global Factor VIII Deficiency Treatment Revenue (Million USD) by Type (2015-2020)
Table 120. Global Factor VIII Deficiency Treatment Revenue Share by Type (2015-2020)
Table 121. Global Factor VIII Deficiency Treatment Revenue Forecast by Type (2021-2025)
Table 122. Global Factor VIII Deficiency Treatment Revenue by Application (2015-2020)
Table 123. Global Factor VIII Deficiency Treatment Revenue Share by Application (2015-2020)
Table 124. Global Factor VIII Deficiency Treatment Revenue Forecast by Application (2021-2025)
Table 125. Global Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Factor VIII Deficiency Treatment Picture
Figure 2. Global Factor VIII Deficiency Treatment Revenue Market Share by Type in 2019
Figure 3. Hemophilia A Drugs Picture
Figure 4. Hemophilia A Inhibitors Treatment Picture
Figure 5. Von Willebrand Disease Treatment Picture
Figure 6. Factor VIII Deficiency Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Factor VIII Deficiency Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Factor VIII Deficiency Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Factor VIII Deficiency Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Factor VIII Deficiency Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Factor VIII Deficiency Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 43. China Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Factor VIII Deficiency Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Factor VIII Deficiency Treatment Revenue Share by Type in 2019
Figure 60. Global Factor VIII Deficiency Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Hemophilia A Drugs Revenue Growth Rate (2015-2020)
Figure 62. Global Hemophilia A Inhibitors Treatment Revenue Growth Rate (2015-2020)
Figure 63. Global Von Willebrand Disease Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Factor VIII Deficiency Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Factor VIII Deficiency Treatment Revenue Share by Application in 2019
Figure 66. Global Factor VIII Deficiency Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Factor VIII Deficiency Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---